Survival bene fi t of cabazitaxel in castration-resistant prostate cancer patients predicted with poor prognosis

被引：0
|
作者：
Hashimoto, Kohei [1 ,3 ]
Tanaka, Toshiaki [1 ,3 ]
Tabata, Hidetoshi [1 ]
Takayanagi, Akio [1 ]
Shindo, Tetsuya [1 ,3 ]
Yamamoto, Takanobu [1 ]
Shibamori, Kosuke [1 ]
Kato, Shuichi [1 ]
Hashimoto, Jiro [1 ]
Inoue, Ryuta [1 ]
Muranaka, Takashi [1 ]
Takahashi, Atsushi [2 ,3 ]
Masumori, Naoya [1 ,3 ]
机构：
[1] Sapporo Med Univ, Sapporo, Hokkaido, Japan
[2] Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan
[3] Sapporo Med Univ, Urol Oncol Consortium, Sapporo, Hokkaido, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
IS-29
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [1] Cabazitaxel in patients with castration-resistant prostate cancer
    Falcao, Gil
    Carneiro, Cabrita
    Pinheiro, Luis Campos
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 25 - 25
  • [2] Cabazitaxel for castration-resistant prostate cancer
    Shigeta, Keisuke
    Miura, Yuji
    Naito, Yoichi
    Takano, Toshimi
    LANCET, 2011, 377 (9760): : 121 - 121
  • [3] Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer
    Blas, Leandro
    Shiota, Masaki
    Tanegashima, Tokiyoshi
    Kobayashi, Satoshi
    Matsumoto, Takashi
    Eto, Masatoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (07) : 829 - 831
  • [4] Risk Factors for Poor Survival in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel in Japan
    Yasuoka, Shotaro
    Yuasa, Takeshi
    Ogawa, Masahiro
    Komai, Yoshinobu
    Numao, Noboru
    Yamamoto, Shinya
    Kondo, Yukihiro
    Yonese, Junji
    ANTICANCER RESEARCH, 2019, 39 (10) : 5803 - 5809
  • [5] Cabazitaxel for the treatment of castration-resistant prostate cancer
    Agarwal, Neeraj
    Sonpavde, Guru
    Sartor, Oliver
    FUTURE ONCOLOGY, 2011, 7 (01) : 15 - 24
  • [6] Cabazitaxel for castration-resistant prostate cancer Reply
    de Bono, Johann Sebastian
    Sartor, Oliver
    LANCET, 2011, 377 (9760): : 122 - 123
  • [7] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
  • [8] Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
    Kreis, Kristine
    Horenkamp-Sonntag, Dirk
    Schneider, Udo
    Zeidler, Jan
    Glaeske, Gerd
    Weissbach, Lothar
    BJU INTERNATIONAL, 2022, 129 (04) : 470 - 479
  • [9] Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy
    Iwamoto, Hiroaki
    Kano, Hiroshi
    Shimada, Takafumi
    Naito, Renato
    Makino, Tomoyuki
    Kadomoto, Suguru
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Kadono, Yoshifumi
    Mizokami, Atsushi
    IN VIVO, 2021, 35 (03): : 1703 - 1709
  • [10] Editorial Comment to Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer
    Yamamoto, Yoshiyuki
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (07) : 831 - 832
12345